These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20032294)

  • 21. Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines.
    Kumar A; Moreau JL; Gibert M; Thèze J
    J Immunol; 1987 Dec; 139(11):3680-4. PubMed ID: 3119713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab.
    Luo J; Wu SJ; Lacy ER; Orlovsky Y; Baker A; Teplyakov A; Obmolova G; Heavner GA; Richter HT; Benson J
    J Mol Biol; 2010 Oct; 402(5):797-812. PubMed ID: 20691190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation.
    Pilson RS; Levin W; Desai B; Reik LM; Lin P; Korkmaz-Duffy E; Campbell E; Tso JY; Kerwin JA; Hakimi J
    J Immunol; 1997 Aug; 159(3):1543-56. PubMed ID: 9233654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basiliximab: a review of its use as induction therapy in renal transplantation.
    McKeage K; McCormack PL
    BioDrugs; 2010 Feb; 24(1):55-76. PubMed ID: 20055533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18.
    Argiriadi MA; Xiang T; Wu C; Ghayur T; Borhani DW
    J Biol Chem; 2009 Sep; 284(36):24478-89. PubMed ID: 19553661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
    Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
    J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
    J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.
    Höcker B; Kovarik JM; Daniel V; Opelz G; Fehrenbach H; Holder M; Hoppe B; Hoyer P; Jungraithmayr TC; Köpf-Shakib S; Laube GF; Müller-Wiefel DE; Offner G; Plank C; Schröder M; Weber LT; Zimmerhackl LB; Tönshoff B
    Transplantation; 2008 Nov; 86(9):1234-40. PubMed ID: 19005405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of human IL-2/IL-2 receptor beta chain interactions: monoclonal antibody H2-8 and new IL-2 mutants define the critical role of alpha helix-A of IL-2.
    Eckenberg R; Xu D; Moreau JL; Bossus M; Mazie JC; Tartar A; Liu XY; Alzari PM; Bertoglio J; Theze J
    Cytokine; 1997 Jul; 9(7):488-98. PubMed ID: 9237811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti IL-2 receptor antibody--basiliximab].
    Nakagawa Y; Saitou K; Takahashi K
    Nihon Rinsho; 2005 May; 63 Suppl 5():713-7. PubMed ID: 15954434
    [No Abstract]   [Full Text] [Related]  

  • 33. Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20.
    Du J; Yang H; Guo Y; Ding J
    Mol Immunol; 2009 Jul; 46(11-12):2419-23. PubMed ID: 19427037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 7 receptor alpha as a potential therapeutic target in transplantation.
    Racapé M; Vanhove B; Soulillou JP; Brouard S
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):253-61. PubMed ID: 19585222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential blood level monitoring of basiliximab during multisession plasmapheresis in a kidney transplant recipient.
    Nojima M; Yoshimoto T; Nakao A; Itahana R; Kyo M; Hashimoto M; Shima H
    Transplant Proc; 2005 Mar; 37(2):875-8. PubMed ID: 15848561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis.
    Du J; Hou S; Zhong C; Lai Z; Yang H; Dai J; Zhang D; Wang H; Guo Y; Ding J
    J Mol Biol; 2008 Oct; 382(4):835-42. PubMed ID: 18694758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
    Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab.
    Ultsch M; Bevers J; Nakamura G; Vandlen R; Kelley RF; Wu LC; Eigenbrot C
    J Mol Biol; 2013 Apr; 425(8):1330-9. PubMed ID: 23357170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
    Mouzaki A; Volk HD; Osawa H; Diamantstein T
    Eur J Immunol; 1987 Mar; 17(3):335-41. PubMed ID: 3106058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES.
    Hall G; Cullen E; Sawmynaden K; Arnold J; Fox S; Cowan R; Muskett FW; Matthews D; Merritt A; Kettleborough C; Cruikshank W; Taylor D; Bayliss R; Carr MD
    J Biol Chem; 2016 Aug; 291(32):16840-8. PubMed ID: 27231345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.